MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential

Go back to MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
(NASDAQ: MTVA) Delayed: 1.54 -0.03 (1.91%)
Previous Close $1.57    52 Week High
Open $1.52    52 Week Low
Day High $1.64    P/E N/A 
Day Low $1.50    EPS
Volume 517,653